H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes

Article metrics

  • An Erratum to this article was published on 13 April 2011


DNA double-strand breaks (DSBs) are generated by the recombination activating gene (RAG) endonuclease in all developing lymphocytes as they assemble antigen receptor genes1. DNA cleavage by RAG occurs only at the G1 phase of the cell cycle and generates two hairpin-sealed DNA (coding) ends that require nucleolytic opening before their repair by classical non-homologous end-joining (NHEJ)1,2,3. Although there are several cellular nucleases that could perform this function, only the Artemis nuclease is able to do so efficiently2,3. Here, in vivo, we show that in murine cells the histone protein H2AX prevents nucleases other than Artemis from processing hairpin-sealed coding ends; in the absence of H2AX, CtIP can efficiently promote the hairpin opening and resection of DNA ends generated by RAG cleavage. This CtIP-mediated resection is inhibited by γ-H2AX and by MDC-1 (mediator of DNA damage checkpoint 1), which binds to γ-H2AX in chromatin flanking DNA DSBs. Moreover, the ataxia telangiectasia mutated (ATM) kinase activates antagonistic pathways that modulate this resection. CtIP DNA end resection activity is normally limited to cells at post-replicative stages of the cell cycle, in which it is essential for homology-mediated repair4,5. In G1-phase lymphocytes, DNA ends that are processed by CtIP are not efficiently joined by classical NHEJ and the joints that do form frequently use micro-homologies and show significant chromosomal deletions. Thus, H2AX preserves the structural integrity of broken DNA ends in G1-phase lymphocytes, thereby preventing these DNA ends from accessing repair pathways that promote genomic instability.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: H2AX inhibits DNA end resection in G1-phase lymphocytes.
Figure 2: ATM and γ-H2AX regulate DNA end resection.
Figure 3: H2AX prevents CtIP-mediated DNA end resection.
Figure 4: Aberrant joining in H2AX-deficient cells.


  1. 1

    Fugmann, S. D., Lee, A. I., Shockett, P. E., Villey, I. J. & Schatz, D. G. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18, 495–527 (2000)

  2. 2

    Lieber, M. R., Ma, Y., Pannicke, U. & Schwarz, K. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amst.) 3, 817–826 (2004)

  3. 3

    Rooney, S., Chaudhuri, J. & Alt, F. W. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol. Rev. 200, 115–131 (2004)

  4. 4

    Huertas, P. DNA resection in eukaryotes: deciding how to fix the break. Nature Struct. Mol. Biol. 17, 11–16 (2010)

  5. 5

    You, Z. & Bailis, J. M. DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints. Trends Cell Biol. 20, 402–409 (2010)

  6. 6

    Yin, B. et al. Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination. J. Exp. Med. 206, 2625–2639 (2009)

  7. 7

    Bredemeyer, A. L. et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442, 466–470 (2006)

  8. 8

    Bredemeyer, A. L. et al. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 456, 819–823 (2008)

  9. 9

    Muljo, S. A. & Schlissel, M. S. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nature Immunol. 4, 31–37 (2003)

  10. 10

    Difilippantonio, S. et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 456, 529–533 (2008)

  11. 11

    Chen, H. T. et al. Response to RAG-mediated VDJ cleavage by NBS1 and γ-H2AX. Science 290, 1962–1965 (2000)

  12. 12

    Savic, V. et al. Formation of dynamic γ-H2AX domains along broken DNA strands is distinctly regulated by ATM and MDC1 and dependent upon H2AX densities in chromatin. Mol. Cell 34, 298–310 (2009)

  13. 13

    Chen, L., Nievera, C. J., Lee, A. Y. & Wu, X. Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J. Biol. Chem. 283, 7713–7720 (2008)

  14. 14

    Deriano, L., Stracker, T. H., Baker, A., Petrini, J. H. & Roth, D. B. Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. Mol. Cell 34, 13–25 (2009)

  15. 15

    Helmink, B. A. et al. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J. Exp. Med. 206, 669–679 (2009)

  16. 16

    Lengsfeld, B. M., Rattray, A. J., Bhaskara, V., Ghirlando, R. & Paull, T. T. Sae2 is an endonuclease that processes hairpin DNA cooperatively with the Mre11/Rad50/Xrs2 complex. Mol. Cell 28, 638–651 (2007)

  17. 17

    Stucki, M. et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123, 1213–1226 (2005)

  18. 18

    Lou, Z. et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 21, 187–200 (2006)

  19. 19

    Melander, F. et al. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J. Cell Biol. 181, 213–226 (2008)

  20. 20

    Chapman, J. R. & Jackson, S. P. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep. 9, 795–801 (2008)

  21. 21

    Spycher, C. et al. Constitutive phosphorylation of MDC1 physically links the MRE11–RAD50–NBS1 complex to damaged chromatin. J. Cell Biol. 181, 227–240 (2008)

  22. 22

    Lloyd, J. et al. A supramodular FHA/BRCT-repeat architecture mediates Nbs1 adaptor function in response to DNA damage. Cell 139, 100–111 (2009)

  23. 23

    Williams, R. S. et al. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 139, 87–99 (2009)

  24. 24

    Bothmer, A. et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J. Exp. Med. 207, 855–865 (2010)

  25. 25

    Bunting, S. F. et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141, 243–254 (2010)

  26. 26

    Xie, A. et al. Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. Mol. Cell 28, 1045–1057 (2007)

  27. 27

    Bassing, C. H. et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114, 359–370 (2003)

  28. 28

    Celeste, A. et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114, 371–383 (2003)

  29. 29

    Zha, S. et al. XLF has redundant functions with ATM and H2AX in V(D)J recombination and non-homologous DNA end-joining. Nature doi:10.1038/nature09604 (this issue).

  30. 30

    Riballo, E. et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to γ-H2AX foci. Mol. Cell 16, 715–724 (2004)

  31. 31

    Shull, E. R. et al. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 23, 171–180 (2009)

  32. 32

    Lu, L. et al. Actin stress fiber pre-extension in human aortic endothelial cells. Cell Motil. Cytoskeleton 65, 281–294 (2008)

  33. 33

    Langer, E. M. et al. Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus . Dev. Cell 14, 424–436 (2008)

  34. 34

    Hegedus, E., Kokai, E., Kotlyar, A., Dombradi, V. & Szabo, G. Separation of 1–23-kb complementary DNA strands by urea-agarose gel electrophoresis. Nucleic Acids Res. 37, e112 (2009)

Download references


We thank E. Oltz and F. Alt for critical review of the manuscript; R. Baer for providing us with the anti-CtIP antibodies; and G. Longmore and Y. Feng for pFLRU, pHR′Δ8.2R and pCMV-VSVg. This work is supported by National Institutes of Health (NIH) grants AI074953 (B.P.S.), AI47829 (B.P.S.), CA136470 (B.P.S. and C.H.B.), CA125195 (C.H.B.), CA21765 (P.J.McK.) and NS37956 (P.J.McK.). J.J.B. is supported by a NIH Ruth L. Kirschstein National Research Service Award (T32 HD007499) and a Children’s Discovery Institute Fellows Award. C.H.B. was a Pew Scholar in the Biomedical Sciences program and is a Leukemia and Lymphoma Society Scholar.

Author information

B.P.S. and B.A.H. conceived the study and wrote the paper. B.P.S. and C.H.B. designed experiments and interpreted data. B.A.H., A.T.T., Y.D., G.S., J.Z. and J.J.B. designed and performed experiments and interpreted data. Z.F. and L.M.W. performed experiments. P.J.McK. provided important reagents.

Correspondence to Barry P. Sleckman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

The file contains Supplementary Figures 1-17 with legends. (PDF 3832 kb)

PowerPoint slides

PowerPoint slide for Fig. 1

PowerPoint slide for Fig. 2

PowerPoint slide for Fig. 3

PowerPoint slide for Fig. 4

Rights and permissions

Reprints and Permissions

About this article

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.